News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,752 Results
Type
Article (45796)
Company Profile (341)
Press Release (662615)
Section
Business (208763)
Career Advice (2219)
Deals (36240)
Drug Delivery (101)
Drug Development (82412)
Employer Resources (173)
FDA (16253)
Job Trends (15205)
News (352402)
Policy (33145)
Tag
Academia (2569)
Alliances (50730)
Alzheimer's disease (1283)
Approvals (16207)
Artificial intelligence (152)
Bankruptcy (362)
Best Places to Work (11683)
Biotechnology (248)
Breast cancer (192)
Cancer (1405)
Cardiovascular disease (115)
Career advice (1839)
CAR-T (103)
Cell therapy (303)
Clinical research (65864)
Collaboration (509)
Compensation (264)
COVID-19 (2591)
C-suite (118)
Data (1411)
Diabetes (178)
Diagnostics (6238)
Earnings (85777)
Employer resources (152)
Events (113818)
Executive appointments (406)
FDA (16951)
Funding (448)
Gene therapy (209)
GLP-1 (630)
Government (4381)
Healthcare (18836)
Infectious disease (2687)
Inflammatory bowel disease (119)
Interviews (352)
IPO (16660)
Job creations (3927)
Job search strategy (1585)
Layoffs (434)
Legal (8066)
Lung cancer (199)
Manufacturing (221)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (19744)
Metabolic disorders (481)
Neuroscience (1622)
NextGen Class of 2024 (6661)
Non-profit (4516)
Northern California (1726)
Obesity (272)
Opinion (226)
Patents (124)
People (58150)
Phase I (20591)
Phase II (29059)
Phase III (21526)
Pipeline (527)
Postmarket research (2589)
Preclinical (8738)
Radiopharmaceuticals (239)
Rare diseases (280)
Real estate (6247)
Regulatory (22162)
Research institute (2365)
Resumes & cover letters (376)
Southern California (1489)
Startups (3816)
United States (15554)
Vaccines (592)
Weight loss (198)
Date
Today (2)
Last 7 days (338)
Last 30 days (2282)
Last 365 days (36068)
2024 (35954)
2023 (40711)
2022 (51900)
2021 (56370)
2020 (54697)
2019 (47160)
2018 (35608)
2017 (33141)
2016 (32600)
2015 (38468)
2014 (33848)
2013 (28963)
2012 (29453)
2011 (30123)
2010 (28203)
Location
Africa (796)
Arizona (199)
Asia (39286)
Australia (6589)
California (3899)
Canada (1469)
China (318)
Colorado (175)
Connecticut (182)
Europe (85409)
Florida (541)
Georgia (136)
Illinois (415)
Indiana (229)
Maryland (648)
Massachusetts (3044)
Michigan (176)
Minnesota (303)
New Jersey (1133)
New York (1102)
North Carolina (776)
Northern California (1726)
Ohio (147)
Pennsylvania (942)
South America (1186)
Southern California (1489)
Texas (565)
Utah (111)
Washington State (407)
708,752 Results for "mesa biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Business
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc., a global leader in the design and manufacture of life science tools and critical quality control solutions, announced results for its fourth fiscal quarter and fiscal year ended March 31, 2024.
June 5, 2024
·
22 min read
Business
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.
April 1, 2024
·
1 min read
Press Releases
Mesa Labs Announces Second Quarter Results
November 8, 2024
·
17 min read
Business
Mesa Labs Declares Quarterly Dividend - April 04, 2024
Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
April 4, 2024
·
2 min read
BioMidwest
Mesa Labs Releases Second Annual Responsible Business Program Brochure
Mesa Laboratories, Inc. announced the release of its second annual Environmental, Social and Governance Program Brochure.
March 15, 2024
·
4 min read
Press Releases
Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa
October 2, 2024
·
3 min read
Business
Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges
Stephen Majors from the Alliance for Regenerative Medicine, which hosts the conference, spoke with
BioSpace
about what the more than 2,000 attendees can expect to learn next week in Phoenix about the pressing issues confronting the industry.
October 3, 2024
·
7 min read
·
Greg Slabodkin
Business
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
September 30, 2024
·
3 min read
1 of 70,876
Next
